Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Covington
Queensland Health
Julphar
Colorcon
Harvard Business School
Fish and Richardson
McKinsey
Deloitte

Generated: April 19, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: remifentanil hydrochloride

« Back to Dashboard

Midazolam

CASRN: 59467-70-8UNII:

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Colorcon
Cerilliant
Mallinckrodt
Medtronic
Citi
Teva
Accenture